KR100369888B1 - 미졸라스틴을함유하는서방성약학적제제물 - Google Patents

미졸라스틴을함유하는서방성약학적제제물 Download PDF

Info

Publication number
KR100369888B1
KR100369888B1 KR10-1998-0706802A KR19980706802A KR100369888B1 KR 100369888 B1 KR100369888 B1 KR 100369888B1 KR 19980706802 A KR19980706802 A KR 19980706802A KR 100369888 B1 KR100369888 B1 KR 100369888B1
Authority
KR
South Korea
Prior art keywords
acid
release pharmaceutical
sustained
tablet
tartaric acid
Prior art date
Application number
KR10-1998-0706802A
Other languages
English (en)
Korean (ko)
Other versions
KR19990087387A (ko
Inventor
마리본느 샤리오
가레스 루이스
쟝 몽뗄
Original Assignee
사노피-신델라보
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-신델라보 filed Critical 사노피-신델라보
Publication of KR19990087387A publication Critical patent/KR19990087387A/ko
Application granted granted Critical
Publication of KR100369888B1 publication Critical patent/KR100369888B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR10-1998-0706802A 1996-03-04 1997-02-28 미졸라스틴을함유하는서방성약학적제제물 KR100369888B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR96/2662 1996-03-04
FR9602662A FR2745500B1 (fr) 1996-03-04 1996-03-04 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine

Publications (2)

Publication Number Publication Date
KR19990087387A KR19990087387A (ko) 1999-12-27
KR100369888B1 true KR100369888B1 (ko) 2003-05-17

Family

ID=9489799

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1998-0706802A KR100369888B1 (ko) 1996-03-04 1997-02-28 미졸라스틴을함유하는서방성약학적제제물

Country Status (35)

Country Link
US (2) US6165507A (US06373033-20020416-M00035.png)
EP (1) EP0906101B1 (US06373033-20020416-M00035.png)
JP (2) JP2000512617A (US06373033-20020416-M00035.png)
KR (1) KR100369888B1 (US06373033-20020416-M00035.png)
CN (1) CN1112929C (US06373033-20020416-M00035.png)
AR (1) AR006082A1 (US06373033-20020416-M00035.png)
AT (1) ATE219365T1 (US06373033-20020416-M00035.png)
AU (1) AU725494B2 (US06373033-20020416-M00035.png)
BG (1) BG63451B1 (US06373033-20020416-M00035.png)
BR (1) BR9707827A (US06373033-20020416-M00035.png)
CA (1) CA2247405C (US06373033-20020416-M00035.png)
CO (1) CO4780020A1 (US06373033-20020416-M00035.png)
CY (1) CY2293B1 (US06373033-20020416-M00035.png)
CZ (1) CZ291418B6 (US06373033-20020416-M00035.png)
DE (1) DE69713505T2 (US06373033-20020416-M00035.png)
DK (1) DK0906101T3 (US06373033-20020416-M00035.png)
EE (1) EE03511B1 (US06373033-20020416-M00035.png)
ES (1) ES2177942T3 (US06373033-20020416-M00035.png)
FR (1) FR2745500B1 (US06373033-20020416-M00035.png)
HK (1) HK1017999A1 (US06373033-20020416-M00035.png)
HU (1) HU227472B1 (US06373033-20020416-M00035.png)
IL (1) IL126050A (US06373033-20020416-M00035.png)
IN (1) IN187739B (US06373033-20020416-M00035.png)
NO (1) NO315841B1 (US06373033-20020416-M00035.png)
NZ (1) NZ331947A (US06373033-20020416-M00035.png)
OA (1) OA10854A (US06373033-20020416-M00035.png)
PL (1) PL189813B1 (US06373033-20020416-M00035.png)
PT (1) PT906101E (US06373033-20020416-M00035.png)
RU (1) RU2173997C2 (US06373033-20020416-M00035.png)
SK (1) SK282112B6 (US06373033-20020416-M00035.png)
TR (1) TR199801574T2 (US06373033-20020416-M00035.png)
TW (1) TW491711B (US06373033-20020416-M00035.png)
UA (1) UA49004C2 (US06373033-20020416-M00035.png)
WO (1) WO1997032584A1 (US06373033-20020416-M00035.png)
ZA (1) ZA971830B (US06373033-20020416-M00035.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
KR100713234B1 (ko) * 2000-10-02 2007-05-02 유에스브이 리미티드 메트포민을 함유하는 지속방출형 약학 조성물 및 이의제조방법
US7052706B2 (en) 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
CA2518442A1 (en) * 2003-03-04 2004-09-16 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
MY156305A (en) 2008-07-28 2016-01-29 Takeda Pharmaceutical Pharmaceutical composition
JP5744412B2 (ja) * 2010-03-26 2015-07-08 テバ製薬株式会社 フロセミド製剤
US20140179712A1 (en) 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JPS62283926A (ja) * 1986-06-02 1987-12-09 Nippon Chemiphar Co Ltd 塩酸ニカルジピン持続性組成物
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤

Also Published As

Publication number Publication date
JP2000512617A (ja) 2000-09-26
AU725494B2 (en) 2000-10-12
TW491711B (en) 2002-06-21
IL126050A0 (en) 1999-05-09
NZ331947A (en) 2000-03-27
PL328763A1 (en) 1999-02-15
NO984035L (no) 1998-10-22
CN1112929C (zh) 2003-07-02
HUP9902458A2 (hu) 2000-05-28
EE03511B1 (et) 2001-10-15
PL189813B1 (pl) 2005-09-30
DE69713505T2 (de) 2003-02-13
RU2173997C2 (ru) 2001-09-27
CA2247405A1 (en) 1997-09-12
CZ291418B6 (cs) 2003-03-12
HK1017999A1 (en) 1999-12-10
ZA971830B (en) 1997-09-04
HU227472B1 (en) 2011-07-28
IL126050A (en) 2004-05-12
OA10854A (fr) 2003-02-05
DK0906101T3 (da) 2002-10-14
HUP9902458A3 (en) 2002-11-28
ATE219365T1 (de) 2002-07-15
SK282112B6 (sk) 2001-11-06
FR2745500B1 (fr) 1998-04-03
EP0906101A1 (fr) 1999-04-07
IN187739B (US06373033-20020416-M00035.png) 2002-06-15
CN1212624A (zh) 1999-03-31
BR9707827A (pt) 1999-07-27
KR19990087387A (ko) 1999-12-27
US20050202089A1 (en) 2005-09-15
EE9800275A (et) 1999-02-15
TR199801574T2 (xx) 1998-11-23
NO984035D0 (no) 1998-09-02
NO315841B1 (no) 2003-11-03
WO1997032584A1 (fr) 1997-09-12
JP2007182451A (ja) 2007-07-19
ES2177942T3 (es) 2002-12-16
CY2293B1 (en) 2003-07-04
PT906101E (pt) 2002-09-30
CZ279198A3 (cs) 1999-01-13
DE69713505D1 (de) 2002-07-25
AR006082A1 (es) 1999-08-11
EP0906101B1 (fr) 2002-06-19
CO4780020A1 (es) 1999-05-26
BG102692A (en) 1999-04-30
UA49004C2 (uk) 2002-09-16
CA2247405C (en) 2004-04-20
SK121098A3 (en) 1999-01-11
FR2745500A1 (fr) 1997-09-05
BG63451B1 (bg) 2002-02-28
US6165507A (en) 2000-12-26
AU1930097A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
US7618649B2 (en) Extended release oral dosage composition
US8003637B2 (en) Stabilized atypical antipsychotic formulation
US7226614B2 (en) Tablet comprising cetirizine and pseudoephedrine
JP2007182451A (ja) ミゾラスチンを含有する徐放性医薬製剤
CA2432644C (en) Pharmaceutical composition comprising aspirintm and cs-747
SK169698A3 (en) Fast-dissolving galanthamine hydrobromide tablet
PL206069B1 (pl) Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę
US20090270448A1 (en) Pharmaceutical formulations comprising clopidogrel
JP4324260B2 (ja) 医薬品調製物、その製造方法及びシランセトロンの安定化のための酸性添加剤の使用
JP2002538197A (ja) ベタヒスチンの徐放性組成物
EP1493435B1 (en) Controlled Release Compositions of Betahistine
JP3576806B2 (ja) アンギオテンシン変換酵素阻害剤とカルシウムチャンネル拮抗剤との固定用量組合せ、製造法、および心血管病の治療におけるその用途
US20050171119A1 (en) Pharmaceutical formulations with modified release
KR20210012082A (ko) 미라베그론 및 탐스로신을 포함하는 약학 조성물
KR20240102908A (ko) 아픽사반을 포함하는 서방성 정제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121226

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20131219

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20141231

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20151217

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20161220

Year of fee payment: 15